(Q44474899)

3 December 2017

title

Polymorphisms of TNF and IL-10 genes and clinical outcome of patients with chronic lymphocytic leukemia (English)

1 reference

3 December 2017

0 references

0 references

1 reference

Barbara Cebula-Obrzut

Barbara Cebula-Obrzut

6

0 references

Krzysztof Warzocha

Krzysztof Warzocha

12

0 references

Wojciech Młynarski

2

Wojciech Mlynarski

1 reference

3 December 2017

1

Ewa Lech-Maranda

1 reference

3 December 2017

11

Tadeusz Robak

1 reference

3 December 2017

5

Agata Pastorczak

1 reference

3 December 2017

4

Maciej Borowiec

1 reference

Olga Grzybowska-Izydorczyk

3 December 2017

3

Olga Grzybowska-Izydorczyk

1 reference

Gabriela Klimkiewicz-Wojciechowska

3 December 2017

7

Gabriela Klimkiewicz-Wojciechowska

1 reference

3 December 2017

10

Aleksandra Kotkowska

1 reference

3 December 2017

Monika Wcislo

8

1 reference

3 December 2017

Miroslaw Majewski

9

1 reference

3 December 2017

publication date

8 December 2012

1 reference

Genes, Chromosomes and Cancer

3 December 2017

published in

1 reference

3 December 2017

volume

52

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

287-296

1 reference

Signalling pathways of the TNF superfamily: a double-edged sword

3 December 2017

cites work

1 reference

Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.

21 January 2018

1 reference

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

LDA—a java-based linkage disequilibrium analyzer

21 January 2018

1 reference

Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms

21 January 2018

1 reference

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

21 January 2018

1 reference

CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation

21 January 2018

1 reference

Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus

21 January 2018

1 reference

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

21 January 2018

1 reference

Cytokines and their role in lymphoid development, differentiation and homeostasis

21 January 2018

1 reference

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

21 January 2018

1 reference

Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma

21 January 2018

1 reference

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

21 January 2018

1 reference

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

High tumor necrosis factor-alpha levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma

21 January 2018

1 reference

Biological functions of tumor necrosis factor cytokines and their receptors

21 January 2018

1 reference

T-cell function in chronic lymphocytic leukaemia

21 January 2018

1 reference

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.

21 January 2018

1 reference

Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms.

21 January 2018

1 reference

An investigation of polymorphism in the interleukin-10 gene promoter

21 January 2018

1 reference

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

21 January 2018

1 reference

Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.

21 January 2018

1 reference

An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles

21 January 2018

1 reference

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation

21 January 2018

1 reference

TNF Deficiency Fails to Protect BAFF Transgenic Mice against Autoimmunity and Reveals a Predisposition to B Cell Lymphoma

21 January 2018

1 reference

Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia

21 January 2018

1 reference

Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study

21 January 2018

1 reference

The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

21 January 2018

1 reference

7 January 2021

Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia

1 reference

7 January 2021

Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen

1 reference

7 January 2021

Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma

1 reference

7 January 2021

Polymorphism of the tumour necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukaemia

1 reference

7 January 2021

TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL)

1 reference

7 January 2021

Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis

1 reference

7 January 2021

The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma

1 reference

7 January 2021

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma

1 reference

7 January 2021

Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status

1 reference

7 January 2021

Tumour necrosis factor gene polymorphisms in lymphoproliferative disease

1 reference

7 January 2021

Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients

1 reference

7 January 2021

Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.22028

1 reference

3 December 2017

1 reference